Rasmussen's encephalitis: Clinical features, pathobiology, and treatment advances

The Lancet Neurology

Volumn 13, Issue 2, 2014, Pages 195-205

  Varadkar, Sophia ^a   Bien, Christian G ^b   Kruse, Carol A ^c   Jensen, Frances E ^d   Bauer, Jan ^e   Pardo, Carlos A ^f   Vincent, Angela ^g   Mathern, Gary W ^c   Cross, J Helen ^h  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b EPILEPSY CENTER BETHEL   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e Medical University of Vienna   (Austria)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTICONVULSIVE AGENT; AUTOANTIBODY; AZATHIOPRINE; BOTULINUM TOXIN; CCL23 CHEMOKINE; CHEMOKINE; CLADRIBINE; CORTICOSTEROID; CXCL9 CHEMOKINE; CYCLOOXYGENASE 2 INHIBITOR; EPITOPE; FAS LIGAND; FINGOLIMOD; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1; MACROPHAGE DERIVED CHEMOKINE; MINOCYCLINE; NATALIZUMAB; PERINDOPRIL; PROTEIN A; RANTES; RITUXIMAB; STEROID; TACROLIMUS; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADAPTIVE IMMUNITY; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; APHERESIS; ASTROCYTE; BRAIN ATROPHY; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); COGNITION; CYTOTOXIC T LYMPHOCYTE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ENCEPHALITIS; EPILEPTIC STATE; EXCITOTOXICITY; GENE EXPRESSION; HEMIPLEGIA; HEMISPHERECTOMY; HISTOPATHOLOGY; HUMAN; HUMORAL IMMUNITY; IMMUNOADSORPTION; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INNATE IMMUNITY; LANGUAGE; MACROPHAGE ACTIVATION; MEDICAL DECISION MAKING; MENTAL DETERIORATION; MICROGLIA; NERVE DEGENERATION; NEUROIMAGING; NEUROIMMUNOLOGY; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT DECISION MAKING; PRIORITY JOURNAL; RASMUSSEN SYNDROME; REHABILITATION CARE; REVIEW; SEIZURE; T LYMPHOCYTE; TRANSCRANIAL MAGNETIC STIMULATION; VAGUS NERVE STIMULATION;

ENCEPHALITIS; HUMANS;

EID: 84892489621     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(13)70260-6     Document Type: Review

References (94)

1. Rasmussen T, Olszewski J, Lloyd-Smith D Focal seizures due to chronic localized encephalitis. Neurology 1958, 8:435-445.
2. Bien CG, Granata T, Antozzi C, et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain 2005, 128:454-471.
3. Olson HE, Lechpammer M, Prabhu SP, et al. Clinical application and evaluation of the Bien diagnostic criteria for Rasmussen encephalitis. Epilepsia 2013, 54:1753-1760.
4. Bien CG, Tiemeier H, Sassen R, et al. Rasmussen encephalitis: Incidence and course under randomized therapy with tacrolimus or intravenous immunoglobulins. Epilepsia 2013, 54:543-550.
5. Lamb K, Scott WJ, Mensah A, et al. Prevalence and clinical outcome of Rasmussen encephalitis in children from the United Kingdom. Dev Med Child Neurol 2013, 55(suppl 1):14.
6. Bien CG, Widman G, Urbach H, et al. The natural history of Rasmussen's encephalitis. Brain 2002, 125:1751-1759.
7. Oguni H, Andermann F, Rasmussen TB The natural history of the syndrome of chronic encephalitis and epilepsy: a study of the MNI series of forty-eight cases. Chronic encephalitis and epilepsy-Rasmussen's syndrome 1991, 7-35. Butterworth-Heinemann, Boston. F. Andermann (Ed.).
8. Granata T, Gobbi G, Spreafico R, et al. Rasmussen's encephalitis: early characteristics allow diagnosis. Neurology 2003, 60:422-425.
9. Thomas JE, Reagan TJ, Klass DW Epilepsia partialis continua. A review of 32 cases. Arch Neurol 1977, 34:266-275.
10. Obeso JA, Rothwell JC, Marsden CD The spectrum of cortical myoclonus. From focal reflex jerks to spontaneous motor epilepsy. Brain 1985, 108:124-193.
11. Longaretti F, Dunkley C, Varadkar S, et al. Evolution of the EEG in children with Rasmussen's syndrome. Epilepsia 2012, 53:1539-1545.
12. Bien CG, Gleissner U, Sassen R, et al. An open study of tacrolimus therapy in Rasmussen encephalitis. Neurology 2004, 62:2106-2109.
13. Thilo B, Stingele R, Knudsen K, et al. A case of Rasmussen encephalitis treated with rituximab. Nat Rev Neurol 2009, 5:458-462.
14. Gray F, Serdaru M, Baron H, et al. Chronic localised encephalitis (Rasmussen's) in an adult with epilepsia partialis continua. J Neurol Neurosurg Psychiatry 1987, 50:747-751.
15. Villani F, Pincherle A, Antozzi C, et al. Adult-onset Rasmussen's encephalitis: anatomical-electrographic-clinical features of 7 Italian cases. Epilepsia 2006, 47(suppl 5):41-46.
16. Hart YM, Andermann F, Fish DR, et al. Chronic encephalitis and epilepsy in adults and adolescents: a variant of Rasmussen's syndrome?. Neurology 1997, 48:418-424.
17. Hennessy MJ, Koutroumanidis M, Dean AF, et al. Chronic encephalitis and temporal lobe epilepsy: a variant of Rasmussen's syndrome?. Neurology 2001, 56:678-681.
18. Bhatjiwale MG, Polkey C, Cox TC, Dean A, Deasy N Rasmussen's encephalitis: neuroimaging findings in 21 patients with a closer look at the basal ganglia. Pediatr Neurosurg 1998, 29:142-148.
19. Frucht S Dystonia, athetosis, and epilepsia partialis continua in a patient with late-onset Rasmussen's encephalitis. Mov Disord 2002, 17:609-612.
20. Chinchilla D, Dulac O, Robain O, et al. Reappraisal of Rasmussen's syndrome with special emphasis on treatment with high doses of steroids. J Neurol Neurosurg Psychiatry 1994, 57:1325-1333.
21. Tobias SM, Robitaille Y, Hickey WF, et al. Bilateral Rasmussen encephalitis: postmortem documentation in a five-year-old. Epilepsia 2003, 44:127-130.
22. Bien CG, Elger CE, Leitner Y, et al. Slowly progressive hemiparesis in childhood as a consequence of Rasmussen encephalitis without or with delayed-onset seizures. Eur J Neurol 2007, 14:387-390.
23. Korn-Lubetzki I, Bien CG, Bauer J, et al. Rasmussen encephalitis with active inflammation and delayed seizures onset. Neurology 2004, 62:984-986.
24. Antel JPM, Rasmussen TM Rasmussen's encephalitis and the new hat. Neurology 1996, 46:9-11.
25. Bien CG, Urbach H, Deckert M, et al. Diagnosis and staging of Rasmussen's encephalitis by serial MRI and histopathology. Neurology 2002, 58:250-257.
26. Chiapparini L, Granata T, Farina L, et al. Diagnostic imaging in 13 cases of Rasmussen's encephalitis: can early MRI suggest the diagnosis?. Neuroradiology 2003, 45:171-183.
27. Yamazaki E, Takahashi Y, Akasaka N, Fujiwara T, Inoue Y Temporal changes in brain MRI findings in Rasmussen syndrome. Epileptic Disord 2011, 13:229-239.
28. Wagner J, Schoene-Bake JC, Bien CG, et al. Automated 3D MRI volumetry reveals regional atrophy differences in Rasmussen encephalitis. Epilepsia 2012, 53:613-621.
29. Larionov S, Konig R, Urbach H, et al. MRI brain volumetry in Rasmussen encephalitis: the fate of affected and "unaffected" hemispheres. Neurology 2005, 64:885-887.
30. Fiorella DJ, Provenzale JM, Edward CR, Crain BJ, Al Sugair A 18F-fluorodeoxyglucose positron emission tomography and MR imaging findings in Rasmussen encephalitis. Am J Neuroradiol 2001, 22:1291-1299.
31. So N, Gloor P Electroencephalographic and electrocorticographic findings in chronic encephalitis of the Rasmussen type. Chronic encephalitis and epilepsy Rasmussen's syndrome 1991, 37-45. Butterworth-Heinemann, Boston. F. Andermann (Ed.).
32. Pardo CA, Vining EP, Guo L, et al. The pathology of Rasmussen syndrome: stages of cortical involvement and neuropathological studies in 45 hemispherectomies. Epilepsia 2004, 45:516-526.
33. Robitaille Y Neuropathologic aspects of chronic encephalitis. Chronic encephalitis and epilepsy. Rasmussen's syndrome 1991, 79-110. Butterworth-Heinemann, Boston. F. Andermann (Ed.).
34. Wang Y, Qin ZH Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis 2010, 15:1382-1402.
35. Hart YM, Andermann F, Robitaille Y, et al. Double pathology in Rasmussen's syndrome: a window on the etiology?. Neurology 1998, 50:731-735.
36. Takei H, Wilfong A, Malphrus A, et al. Dual pathology in Rasmussen's encephalitis: a study of seven cases and review of the literature. Neuropathology 2010, 30:381-391.
37. Iyer A, Zurolo E, Spliet WGM, et al. Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias. Epilepsia 2010, 51:1763-1773.
38. Vincent A, Bien CG, Irani SR, Waters P Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 2011, 10:759-772.
39. Lancaster E, Dalmau J Neuronal autoantigens - pathogenesis, associated disorders and antibody testing. Nat Rev Neurol 2012, 8:380-390.
40. Rogers SW, Andrews PI, Gahring LC, et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 1994, 265:648-651.
41. Wiendl HM, Bien CGM, Bernasconi PP, et al. GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis. Neurology 2001, 57:1511-1514.
42. Watson R, Jiang Y, Bermudez I, et al. Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis. Neurology 2004, 63:43-50.
43. Mantegazza R, Bernasconi P, Baggi F, et al. Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J Neuroimmunol 2002, 131:179-185.
44. Granata T, Fusco L, Gobbi G, et al. Experience with immunomodulatory treatments in Rasmussen's encephalitis. Neurology 2003, 61:1807-1810.
45. Watson R, Jepson JE, Bermudez I, et al. Alpha7-acetylcholine receptor antibodies in two patients with Rasmussen encephalitis. Neurology 2005, 65:1802-1804.
46. Alvarez-Baron E, Bien CG, Schramm J, et al. Autoantibodies to Munc18, cerebral plasma cells and B-lymphocytes in Rasmussen encephalitis. Epilepsy Res 2008, 80:93-97.
47. Yang R, Puranam RS, Butler LS, et al. Autoimmunity to munc-18 in Rasmussen's encephalitis. Neuron 2000, 28:375-383.
48. Greiner H, Leach JL, Lee KH, Krueger DA Anti-NMDA receptor encephalitis presenting with imaging findings and clinical features mimicking Rasmussen syndrome. Seizure 2011, 20:266-270.
49. Bien CG, Bauer J, Deckwerth TL, et al. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis. Ann Neurol 2002, 51:311-318.
50. Schwab N, Bien CG, Waschbisch A, et al. CD8+ T cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery. Brain 2009, 132:1236-1246.
51. Bauer J, Elger CE, Hans VH, et al. Astrocytes are a specific immunological target in Rasmussen's encephalitis. Ann Neurol 2007, 62:67-80.
52. Friedman H, Ch'ien L, Parham D Virus in brain of child with hemiplegia, hemiconvulsions, and epilepsy. Lancet 1977, 310:666.
53. Walter GF, Renella RR Epstein-Barr virus in brain and Rasmussen's encephalitis. Lancet 1989, 1:279-280.
54. Power C, Poland SD, Blume WT, Girvin JP, Rice GP Cytomegalovirus and Rasmussen's encephalitis. Lancet 1990, 336:1282-1284.
55. Jay V, Becker LE, Otsubo H, et al. Chronic encephalitis and epilepsy (Rasmussen's encephalitis): detection of cytomegalovirus and herpes simplex virus 1 by the polymerase chain reaction and in situ hybridization. Neurology 1995, 45:108-117.
56. Wirenfeldt M, Clare R, Tung S, et al. Increased activation of Iba1+ microglia in pediatric epilepsy patients with Rasmussen's encephalitis compared with cortical dysplasia and tuberous sclerosis complex. Neurobiol Dis 2009, 34:432-440.
57. Vezzani A, Granata T Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 2005, 46:1724-1743.
58. Balosso S, Maroso M, Sanchez-Alavez M, et al. A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta. Brain 2008, 131:3256-3265.
59. Schafer DP, Lehrman EK, Kautzman AG, et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 2012, 74:691-705.
60. Stephan AH, Barres BA, Stevens B The complement system: an unexpected role in synaptic pruning during development and disease. Annu Rev Neurosci 2012, 35:369-389.
61. Aronica E, Ravizza T, Zurolo E, Vezzani A Astrocyte immune responses in epilepsy. Glia 2012, 60:1258-1268.
62. Ivens S, Kaufer D, Flores L, et al. TGF-b receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain 2007, 130:535-547.
63. + T cells, TNFa, and Granzyme B in CSF. Epilepsia 2009, 50:1419-1431.
64. Owens GC, Huynh M, Chang JW, et al. Differential expression of Interferon-ã and chemokines genes distinguishes Rasmussen encephalitis from cortical dysplasia and provides evidence for an early Th1 immune response. J Neuroinflammation 2013, 10:56.
65. Bien CG, Schramm J Treatment of Rasmussen encephalitis half a century after its initial description: promising prospects and a dilemma. Epilepsy Res 2009, 86:101-112.
66. Dubeau F, Sherwin AL Pharmacologic principles in the management of chronic focal encephalitis. Chronic encephalitis and epilepsy Rasmussen's syndrome 1991, 179-192. Butterworth-Heinemann, Boston. F. Andermann (Ed.).
67. Browner N, Azher SN, Jankovic J Botulinum toxin treatment of facial myoclonus in suspected Rasmussen encephalitis. Mov Disord 2006, 21:1500-1502.
68. Lozsadi DA, Hart IK, Moore AP Botulinum toxin A improves involuntary limb movements in Rasmussen syndrome. Neurology 2004, 62:1233-1234.
69. Laxer KD, Wilfong A, Morris GLI, Andermann F Pilot study of Rituximab to treat chronic focal encephalitis. Epilepsia 2008, 49:121.
70. Grujic J, Bien CG, Pollo C, Rossetti AO Vagus nerve stimulator treatment in adult-onset Rasmussen's encephalitis. Epilepsy Behav 2011, 20:123-125.
71. San-Juan D, Calcaneo JD, Gonzalez-Aragon MF, et al. Transcranial direct current stimulation in adolescent and adult Rasmussen's encephalitis. Epilepsy Behav 2011, 20:126-131.
72. Bahi-Buisson N, Nabbout R, Plouin P, et al. Recent advances in pathogenic concepts and therapeutic strategies in Rasmussen's encephalitis. Rev Neurol (Paris) 2005, 161:395-405.
73. Hart Y, Andermann F, Fish D, et al. The medical treatment of chronic encephalitis and epilepsy. Epileptic seizures and syndromes 1994, 399-404. John Libbey & Company, London. P. Wolf (Ed.).
74. Hart YM, Cortez M, Andermann F, et al. Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy): effect of high-dose steroids or immunoglobulins in 19 patients. Neurology 1994, 44:1030-1036.
75. Villani F, Spreafico R, Farina L, et al. Positive response to immunomodulatory therapy in an adult patient with Rasmussen's encephalitis. Neurology 2001, 56:248-250.
76. Leach JP, Chadwick DW, Miles JB, Hart IK Improvement in adult-onset Rasmussen's encephalitis with long-term immunomodulatory therapy. Neurology 1999, 52:738-742.
77. Antozzi C, Granata T, Aurisano N, et al. Long-term selective IgG immuno-adsorption improves Rasmussen's encephalitis. Neurology 1998, 51:302-305.
78. Andrews PIF, Dichter MAM, Berkovic SFF, Newton MRF, McNamara JOM Plasmapheresis in Rasmussen's encephalitis. Neurology 1996, 46:242-246.
79. Varadkar S, Chong WK, Robinson R, et al. Azathioprine therapy in Rasmussen Syndrome. Epilepsy Currents 2012, 12(suppl 1):417.
80. Takahashi Y, Yamazaki E, Mine J, et al. Immunomodulatory therapy versus surgery for Rasmussen syndrome in early childhood. Brain Devel 2013, 35:778-785.
81. Daniel RT, Villemure JG Experience with immunomodulatory treatments in Rasmussen's encephalitis. Neurology 2004, 63:1761-1762.
82. Barten LJ, Allington DR, Procacci KA, Rivey MP New approaches in the management of multiple sclerosis. Drug Des Devel Ther 2010, 4:343-366.
83. Dong YF, Kataoka K, Tokutomi Y, et al. Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease. FASEB J 2011, 25:2911-2920.
84. Bittner S, Simon OJ, Göbel K, et al. A case of Rasmussen's encephalitis treated with natalizumab. Neurology 2013, 81:395-397.
85. Pulsifer MB, Brandt J, Salorio CF, et al. The cognitive outcome of hemispherectomy in 71 children. Epilepsia 2004, 45:243-254.
86. Jonas R, Nguyen S, Hu B, et al. Cerebral hemispherectomy: hospital course, seizure, developmental, language, and motor outcomes. Neurology 2004, 62:1712-1721.
87. Thomas SG, Chacko AG, Thomas MM, et al. Outcomes of disconnective surgery in intractable pediatric hemispheric and subhemispheric epilepsy. Int J Pediatr 2012, 2012:527891.
88. Althausen A, Gleissner U, Hoppe C, et al. Long-term outcome of hemispheric surgery at different ages in 61 epilepsy patients. J Neurol Neurosurg Psychiatry 2013, 84:529-536.
89. Vora N, Cross JH, Robinson R, et al. Epilepsy Surgery in Rasmussen Syndrome. Epilepsy Currents 2012, 12:296.
90. Vining E, Freeman J, Pillas D, et al. Why Would You Remove Half a Brain? The Outcome of 58 Children After Hemispherectomy-The Johns Hopkins Experience: 1968 to 1996. Pediatrics 1997, 100:163-171.
91. Hertz-Pannier L, Chiron C, Jambaque I, et al. Late plasticity for language in a child's non-dominant hemisphere: a pre- and post-surgery fMRI study. Brain 2002, 125:361-372.
92. Boatman D, Freeman J, Vining E, et al. Language recovery after left hemispherectomy in children with late-onset seizures. Ann Neurol 1999, 46:579-586.
93. Andermann E, Oguni H, Guttmann RD, et al. Genetic aspects of chronic encephalitis. Chronic encephalitis and epilepsy: Rasmussen's syndrome 1991, 167-175. Butterworth-Heinemann, Boston. F. Andermann (Ed.).
94. Ohmori I, Ouchida M, Kobayashi K, et al. Rasmussen encephalitis associated with SCN 1 A mutation. Epilepsia 2008, 49:521-526.